Folic Acid Market To Reach $1.40 Billion By 2030 | CAGR: 5.1%

Folic Acid Market Growth & Trends

The global folic acid market size is expected to reach USD 1.40 billion by 2030, registering a CAGR of 5.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing consumption of vitamin B9 as a source of an essential supplement during pregnancy by women that minimizes the risk of congenital disabilities in infants is anticipated to augment the market demand in the coming years.

Folic acid is required for the metabolism of specific biochemical reactions and cell division in the body. It plays a significant role in the development of the nervous system in the growing fetus. Moreover, it is involved in the formation of red blood cells, supporting the normal development of the neural tube in the fetus. Market drivers include the increasing demand from pharmaceutical and nutraceuticals industry for manufacturing instant folate-rich food products owing to its health benefits.

Improved medical facilities, increasing disposable income and adoption of social programs by the government to encourage healthcare initiatives have led to growing demand folic acid products. Pharmaceuticals dominated the market in 2015, followed by nutraceuticals. Asia Pacific dominated the folic acid market in 2015 due to the high production of the raw material in emerging economies such as China, which is a primary manufacturer of the vitamins globally.

Companies such as BASF SE, Zydus Pharmaceuticals Ltd., Medicamen Biotech Ltd., Jiangxi Tianxin Pharmaceutical Co. Ltd., Koninklijke DSM N.V., and Emcure Pharmaceuticals Ltd. have implemented acquisition and expansion business strategies to increase their geographical presence. Few global players have invested in R&D amenities to discover advanced and innovative folic products with higher efficacy rate and ease of use.

 Request a free sample copy or view report summary: Folic Acid Market Report

Folic Acid Market Report Highlights

• The food & beverages segment dominated the global folic acid market based on application, with a revenue share of 38.8% in 2024.

• The pharmaceuticals segment is also expected to experience the fastest CAGR from 2025 to 2030. Pharmaceutical formulations incorporating folic acid as the active ingredient are widely utilized in the treatment of patients exhibiting folate-deficient anemia.

• The offline segment held the largest revenue share of the folic acid market in 2024. A substantial proportion of end-users who incorporate folic acid into their product formulations exhibit a preference for offline procurement channels.

• The North America folic acid industry dominated the global market, with a revenue share of 32.8% in 2024. The region exhibits a high prevalence of folate-deficiency anemia, which has stimulated demand for fortified food products containing folic acid.

• The Asia Pacific folic acid market is anticipated to experience the fastest CAGR during the forecast period.

Folic Acid Market Segmentation

Grand View Research has segmented global folic acid market report based on application, distribution channel, and region:

Folic Acid Application Outlook (Revenue, USD Million, 2018 - 2030)

• Food & Beverages

• Pharmaceuticals

• Nutraceuticals

• Others

Folic Acid Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Offline

• Online

Folic Acid Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

• Asia Pacific

  • China

  • India

  • Japan

  • Australia & New Zealand

  • South Korea

• Central & South America

  • Argentina

• MEA

  • South Africa

List of Key Players of Folic Acid Market

• BASF SE

• Zydus Pharmaceuticals Ltd.

• Medicamen Biotech Ltd.

• Emcure Pharmaceuticals Ltd.

• Jiangxi Tianxin Pharmaceutical Co. Ltd.

• Xinjiang Wujiaqu Xingnong Cycle Chemical Co. Ltd.

• Changzhou Niutang Chemical Plant Co. Ltd.

• Shandong Xinfa Pharmaceutical Co., Ltd.

• Hebei Jiheng Group Pharmacy Co Ltd.